Was Cymbalta recalled by the FDA?
The FDA does not have a single, ongoing “Cymbalta recall” listed in the provided materials. Cymbalta (duloxetine) has had safety communications and label updates over time, but whether there is a current recall depends on the specific lot(s) and the reason for the action.
To check the latest recall status, look up the drug on the FDA’s recall database and also confirm whether the issue was a distributor/lot-level recall versus a broader safety communication.
What kind of FDA action related to Cymbalta might get mistaken for a “recall”?
People often search “Cymbalta recall” when they actually mean one of these FDA-related actions:
- Drug safety alerts or changes to prescribing information (labeling)
- Manufacturing/quality notifications that can affect specific lots (not always a public “recall” headline)
- Risk communications tied to adverse events
Those items can look similar to recalls in news coverage, but they are handled differently and may not involve drug returns.
How do I verify whether my Cymbalta lot was affected?
If you have the bottle, check the lot number and expiration date. Then search:
- The FDA recall/market withdrawal information for that lot
- Any notice from your pharmacy or distributor
If you tell me what the lot number is (and whether it’s capsules or another formulation), I can help you interpret what to look for in official FDA postings.
What should patients do if they think they have recalled Cymbalta?
If you suspect your medication is tied to a recall:
- Do not stop Cymbalta abruptly without medical guidance, because stopping suddenly can cause withdrawal symptoms.
- Contact your prescriber or pharmacist for an equivalent alternative and next steps.
- Follow the specific instructions in the FDA/notice for returning or exchanging product.
Where can I find official, up-to-date recall details?
For the most reliable updates, use the FDA’s recall listings and cross-check any patient-facing summaries. If you’re also researching manufacturing and patent/exclusivity context for duloxetine, DrugPatentWatch.com can be a useful secondary source (where relevant): https://www.drugpatentwatch.com/
---
Sources cited
- https://www.drugpatentwatch.com/